{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:13Z","timestamp":1761630493270},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T00:00:00Z","timestamp":1221696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> We report the case of a 54\u2010year\u2010old woman who underwent living\u2010related renal transplantation for end\u2010stage renal disease from IgA nephropathy. She was subsequently diagnosed with antibody\u2010mediated rejection (AMR) and received rituximab, a potent B\u2010cell suppressive agent. After therapy with rituximab, she developed <jats:italic>Pneumocystis jirovecii<\/jats:italic> pneumonia (PJP) requiring hospitalization. We discuss the increasing literature for the use of rituximab for AMR and the need for PJP prophylaxis in this setting.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2008.00345.x","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T09:59:30Z","timestamp":1221731970000},"page":"167-170","source":"Crossref","is-referenced-by-count":32,"title":["<i>Pneumocystis jirovecii<\/i> pneumonia after rituximab therapy for antibody\u2010mediated rejection in a renal transplant recipient"],"prefix":"10.1111","volume":"11","author":[{"given":"D.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gourishankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cockfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Weinkauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vethanayagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Humar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,7]]},"reference":[{"issue":"10","key":"e_1_2_4_2_2","first-page":"135","article-title":"Pneumocystis jiroveci (formerly Pneumocystis carinii)","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"e_1_2_4_3_2","first-page":"859","article-title":"Rituximab, an anti\u2010cd20 monoclonal antibody","volume":"6","author":"Pescovitz MD.","year":"2006","journal-title":"history and mechanism of action"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2006.00345.x"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00454.x"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00994.x"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10564"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200009270-00006"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00507.x"},{"key":"e_1_2_4_10_2","first-page":"84","article-title":"Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients","volume":"5","author":"Radisic M","year":"2003","journal-title":"a case\u2013control study"},{"key":"e_1_2_4_11_2","first-page":"2825","article-title":"Rituximab chimeric anti\u2010CD20 monoclonal antibody therapy for relapsed indolent lymphoma","volume":"16","author":"McLaughlin P","year":"1998","journal-title":"half of patients respond to a four-dose treatment program"},{"key":"e_1_2_4_12_2","article-title":"Rituximab inhibits structural joint damage in rheumatoid arthritis patients with an inadequate response to tumour necrosis factor inhibitor therapies","author":"Keystone EC","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"44","key":"e_1_2_4_13_2","first-page":"S23","article-title":"Adjunction of rituximab to steroids and immunosuppressants for refractory\/relapsing Wegener's granulomatosis","volume":"25","author":"Brihaye B","year":"2007","journal-title":"a study on 8 patients"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2007.00700.x"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.6147"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.4.1034"},{"key":"e_1_2_4_17_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CDLI.6.2.149-155.1999","article-title":"Immunologic features of Pneumocystis infection in humans","volume":"6","author":"Walzer PD.","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(89)90021-4"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200103000-00005"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2008.00345.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2008.00345.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T23:09:11Z","timestamp":1697152151000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2008.00345.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1399-3062.2008.00345.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2008.00345.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}